Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose

Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose

US Patent 11542309 · Granted Jan 3, 2023

Estimated economic value: $11,592,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for treating age-related diabetes and related disorders2025
Compositions and methods for treating age-related diabetes and related disorders2025
Compositions and methods for treating age-related diabetes and related disorders2025
Compositions and methods for treating age-related diabetes and related disorders2025
Compositions and methods for treating type 1 and type 2 diabetes and related dis2025
Compositions and methods for treating type 1 and type 2 diabetes and related dis2025
Compositions and methods for treating type 1 and type 2 diabetes and related dis2025
Compositions and methods for treating type 1 and type 2 diabetes and related dis2025
Reprogramming progenitor compositions and methods of use thereof2024
Reprogramming progenitor compositions and methods of use thereof2024
Reprogramming progenitor compositions and methods of use thereof2024
Reprogramming progenitor compositions and methods of use thereof2024